Issues in anticoagulant therapy: recent trials start to answer the tough questions.
Recent trials provide evidence to help guide the management of patients with recurrent episodes of venous thromboembolism, cancer patients with venous thromboembolism, and patients receiving anticoagulant therapy who must undergo surgery.
Jaffer
Amir K
AK
IMPACT Center, Department of General Internal Medicine, The Cleveland Clinic Foundation, OH 44195, USA. jaffer@ccf.org
D002986:Clinical Trials as Topic; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D009369:Neoplasms / Q000150:complications; D012307:Risk Factors; D055502:Secondary Prevention; D013923:Thromboembolism / Q000188:drug therapy*; D020246:Venous Thrombosis / Q000188:drug therapy*
D006495:Heparin, Low-Molecular-Weight